Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 12, 2020

SELL
$19.57 - $23.52 $4,344 - $5,221
-222 Closed
0 $0
Q3 2018

Nov 07, 2018

BUY
$19.97 - $21.96 $4,433 - $4,875
222 New
222 $4,000
Q2 2018

Aug 08, 2018

SELL
$20.16 - $24.68 $4,475 - $5,478
-222 Closed
0 $0
Q4 2017

Apr 23, 2018

BUY
$20.99 - $23.89 $4,659 - $5,303
222
222 $5,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.57B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Whitener Capital Management, Inc. Portfolio

Follow Whitener Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whitener Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Whitener Capital Management, Inc. with notifications on news.